Pneumococcal Vaccine Market Research Report by Type (Conjugate Vaccines and Polysaccharide Vaccines), by Indication (Bronchitis, Meningitis, Pneumonia, and Sepsis), by Product, by Distribution - Global Forecast to 2025 - Cumulative Impact of COVID-19
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Pneumococcal Vaccine Market is expected to grow from USD 8,121.18 Million in 2020 to USD 11,905.54 Million by the end of 2025.
2. The Global Pneumococcal Vaccine Market is expected to grow from EUR 7,120.80 Million in 2020 to EUR 10,439.01 Million by the end of 2025.
3. The Global Pneumococcal Vaccine Market is expected to grow from GBP 6,330.41 Million in 2020 to GBP 9,280.30 Million by the end of 2025.
4. The Global Pneumococcal Vaccine Market is expected to grow from JPY 866,735.69 Million in 2020 to JPY 1,270,623.87 Million by the end of 2025.
5. The Global Pneumococcal Vaccine Market is expected to grow from AUD 11,793.03 Million in 2020 to AUD 17,288.44 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Pneumococcal Vaccine to forecast the revenues and analyze the trends in each of the following sub-markets:
'The Conjugate Vaccines is projected to witness the highest growth during the forecast period'
Based on Type, the Pneumococcal Vaccine Market studied across Conjugate Vaccines and Polysaccharide Vaccines. The Polysaccharide Vaccines commanded the largest size in the Pneumococcal Vaccine Market in 2020. On the other hand, the Conjugate Vaccines is expected to grow at the fastest CAGR during the forecast period.
'The Pneumonia is projected to witness the highest growth during the forecast period'
Based on Indication, the Pneumococcal Vaccine Market studied across Bronchitis, Meningitis, Pneumonia, and Sepsis. The Meningitis commanded the largest size in the Pneumococcal Vaccine Market in 2020. On the other hand, the Pneumonia is expected to grow at the fastest CAGR during the forecast period.
'The Pneumovax23 is projected to witness the highest growth during the forecast period'
Based on Product, the Pneumococcal Vaccine Market studied across Pneumovax23, Prevnar 13, and Synflorix. The Prevnar 13 commanded the largest size in the Pneumococcal Vaccine Market in 2020. On the other hand, the Pneumovax23 is expected to grow at the fastest CAGR during the forecast period.
'The Non-governmental Organizations is projected to witness the highest growth during the forecast period'
Based on Distribution, the Pneumococcal Vaccine Market studied across Government Authorities and Non-governmental Organizations. The Government Authorities commanded the largest size in the Pneumococcal Vaccine Market in 2020. On the other hand, the Non-governmental Organizations is expected to grow at the fastest CAGR during the forecast period.
'The Asia-Pacific is projected to witness the highest growth during the forecast period'
Based on Geography, the Pneumococcal Vaccine Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded the largest size in the Pneumococcal Vaccine Market in 2020. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Pneumococcal Vaccine Market including Astellas Pharma Inc., AstraZeneca PLC, CSL Limited, Emergent BioSolutions Inc., GlaxoSmithKline PLC, Johnson & Johnson, Merck & Co., Inc., Pfizer Inc., Sanofi S.A., and Serum Institute of India Pvt. Ltd..
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Pneumococcal Vaccine Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Pneumococcal Vaccine Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Pneumococcal Vaccine Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Pneumococcal Vaccine Market?
4. What is the competitive strategic window for opportunities in the Global Pneumococcal Vaccine Market?
5. What are the technology trends and regulatory frameworks in the Global Pneumococcal Vaccine Market?
6. What are the modes and strategic moves considered suitable for entering the Global Pneumococcal Vaccine Market?
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Pneumococcal Vaccine Market is expected to grow from USD 8,121.18 Million in 2020 to USD 11,905.54 Million by the end of 2025.
2. The Global Pneumococcal Vaccine Market is expected to grow from EUR 7,120.80 Million in 2020 to EUR 10,439.01 Million by the end of 2025.
3. The Global Pneumococcal Vaccine Market is expected to grow from GBP 6,330.41 Million in 2020 to GBP 9,280.30 Million by the end of 2025.
4. The Global Pneumococcal Vaccine Market is expected to grow from JPY 866,735.69 Million in 2020 to JPY 1,270,623.87 Million by the end of 2025.
5. The Global Pneumococcal Vaccine Market is expected to grow from AUD 11,793.03 Million in 2020 to AUD 17,288.44 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Pneumococcal Vaccine to forecast the revenues and analyze the trends in each of the following sub-markets:
'The Conjugate Vaccines is projected to witness the highest growth during the forecast period'
Based on Type, the Pneumococcal Vaccine Market studied across Conjugate Vaccines and Polysaccharide Vaccines. The Polysaccharide Vaccines commanded the largest size in the Pneumococcal Vaccine Market in 2020. On the other hand, the Conjugate Vaccines is expected to grow at the fastest CAGR during the forecast period.
'The Pneumonia is projected to witness the highest growth during the forecast period'
Based on Indication, the Pneumococcal Vaccine Market studied across Bronchitis, Meningitis, Pneumonia, and Sepsis. The Meningitis commanded the largest size in the Pneumococcal Vaccine Market in 2020. On the other hand, the Pneumonia is expected to grow at the fastest CAGR during the forecast period.
'The Pneumovax23 is projected to witness the highest growth during the forecast period'
Based on Product, the Pneumococcal Vaccine Market studied across Pneumovax23, Prevnar 13, and Synflorix. The Prevnar 13 commanded the largest size in the Pneumococcal Vaccine Market in 2020. On the other hand, the Pneumovax23 is expected to grow at the fastest CAGR during the forecast period.
'The Non-governmental Organizations is projected to witness the highest growth during the forecast period'
Based on Distribution, the Pneumococcal Vaccine Market studied across Government Authorities and Non-governmental Organizations. The Government Authorities commanded the largest size in the Pneumococcal Vaccine Market in 2020. On the other hand, the Non-governmental Organizations is expected to grow at the fastest CAGR during the forecast period.
'The Asia-Pacific is projected to witness the highest growth during the forecast period'
Based on Geography, the Pneumococcal Vaccine Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded the largest size in the Pneumococcal Vaccine Market in 2020. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Pneumococcal Vaccine Market including Astellas Pharma Inc., AstraZeneca PLC, CSL Limited, Emergent BioSolutions Inc., GlaxoSmithKline PLC, Johnson & Johnson, Merck & Co., Inc., Pfizer Inc., Sanofi S.A., and Serum Institute of India Pvt. Ltd..
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Pneumococcal Vaccine Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Pneumococcal Vaccine Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Pneumococcal Vaccine Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Pneumococcal Vaccine Market?
4. What is the competitive strategic window for opportunities in the Global Pneumococcal Vaccine Market?
5. What are the technology trends and regulatory frameworks in the Global Pneumococcal Vaccine Market?
6. What are the modes and strategic moves considered suitable for entering the Global Pneumococcal Vaccine Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Product Outlook
3.4. Type Outlook
3.5. Indication Outlook
3.6. Distribution Outlook
3.7. Geography Outlook
3.8. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of pneumococcal contamination
5.1.1.2. Upsurge in the awareness programs regarding the proper vaccination
5.1.2. Restraints
5.1.2.1. High cost associated with the development of pneumococcal vaccines
5.1.3. Opportunities
5.1.3.1. Introduction of novel pneumococcal vaccines
5.1.3.2. New developments in adult vaccination
5.1.4. Challenges
5.1.4.1. Slow processing of clinical trials for the production of vaccine
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL PNEUMOCOCCAL VACCINE MARKET, BY TYPE
6.1. Introduction
6.2. Conjugate Vaccines
6.3. Polysaccharide Vaccines
7. GLOBAL PNEUMOCOCCAL VACCINE MARKET, BY INDICATION
7.1. Introduction
7.2. Bronchitis
7.3. Meningitis
7.4. Pneumonia
7.5. Sepsis
8. GLOBAL PNEUMOCOCCAL VACCINE MARKET, BY PRODUCT
8.1. Introduction
8.2. Pneumovax23
8.3. Prevnar
8.4. Synflorix
9. GLOBAL PNEUMOCOCCAL VACCINE MARKET, BY DISTRIBUTION
9.1. Introduction
9.2. Government Authorities
9.3. Non-governmental Organizations
10. AMERICAS PNEUMOCOCCAL VACCINE MARKET
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. South Korea
11.10. Thailand
12. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom
13. COMPETITIVE LANDSCAPE
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis
13.4. Competitor SWOT Analysis
13.5. Competitive Scenario
13.5.1. Merger & Acquisition
13.5.2. Agreement, Collaboration, & Partnership
13.5.3. New Product Launch & Enhancement
13.5.4. Investment & Funding
13.5.5. Award, Recognition, & Expansion
14. COMPANY USABILITY PROFILES
14.1. Astellas Pharma Inc.
14.2. AstraZeneca PLC
14.3. CSL Limited
14.4. Emergent BioSolutions Inc.
14.5. GlaxoSmithKline PLC
14.6. Johnson & Johnson
14.7. Merck & Co., Inc.
14.8. Pfizer Inc.
14.9. Sanofi S.A.
14.10. Serum Institute of India Pvt. Ltd.
15. APPENDIX
15.1. Discussion Guide
15.2. License & Pricing
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Product Outlook
3.4. Type Outlook
3.5. Indication Outlook
3.6. Distribution Outlook
3.7. Geography Outlook
3.8. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of pneumococcal contamination
5.1.1.2. Upsurge in the awareness programs regarding the proper vaccination
5.1.2. Restraints
5.1.2.1. High cost associated with the development of pneumococcal vaccines
5.1.3. Opportunities
5.1.3.1. Introduction of novel pneumococcal vaccines
5.1.3.2. New developments in adult vaccination
5.1.4. Challenges
5.1.4.1. Slow processing of clinical trials for the production of vaccine
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL PNEUMOCOCCAL VACCINE MARKET, BY TYPE
6.1. Introduction
6.2. Conjugate Vaccines
6.3. Polysaccharide Vaccines
7. GLOBAL PNEUMOCOCCAL VACCINE MARKET, BY INDICATION
7.1. Introduction
7.2. Bronchitis
7.3. Meningitis
7.4. Pneumonia
7.5. Sepsis
8. GLOBAL PNEUMOCOCCAL VACCINE MARKET, BY PRODUCT
8.1. Introduction
8.2. Pneumovax23
8.3. Prevnar
8.4. Synflorix
9. GLOBAL PNEUMOCOCCAL VACCINE MARKET, BY DISTRIBUTION
9.1. Introduction
9.2. Government Authorities
9.3. Non-governmental Organizations
10. AMERICAS PNEUMOCOCCAL VACCINE MARKET
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. South Korea
11.10. Thailand
12. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom
13. COMPETITIVE LANDSCAPE
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis
13.4. Competitor SWOT Analysis
13.5. Competitive Scenario
13.5.1. Merger & Acquisition
13.5.2. Agreement, Collaboration, & Partnership
13.5.3. New Product Launch & Enhancement
13.5.4. Investment & Funding
13.5.5. Award, Recognition, & Expansion
14. COMPANY USABILITY PROFILES
14.1. Astellas Pharma Inc.
14.2. AstraZeneca PLC
14.3. CSL Limited
14.4. Emergent BioSolutions Inc.
14.5. GlaxoSmithKline PLC
14.6. Johnson & Johnson
14.7. Merck & Co., Inc.
14.8. Pfizer Inc.
14.9. Sanofi S.A.
14.10. Serum Institute of India Pvt. Ltd.
15. APPENDIX
15.1. Discussion Guide
15.2. License & Pricing
LIST OF TABLES
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY POLYSACCHARIDE VACCINES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY BRONCHITIS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY MENINGITIS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY PNEUMONIA, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY SEPSIS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY PNEUMOVAX23, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY PREVNAR 13, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY SYNFLORIX, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY GOVERNMENT AUTHORITIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY NON-GOVERNMENTAL ORGANIZATIONS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. ARGENTINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. ARGENTINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. ARGENTINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. ARGENTINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. BRAZIL PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. BRAZIL PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. BRAZIL PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. BRAZIL PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. CANADA PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. CANADA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. CANADA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. CANADA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. MEXICO PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. MEXICO PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. MEXICO PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. MEXICO PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. UNITED STATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. UNITED STATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. UNITED STATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. UNITED STATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. AUSTRALIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. AUSTRALIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. AUSTRALIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. AUSTRALIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. CHINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. CHINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. CHINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. CHINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. INDIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. INDIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. INDIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. INDIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. INDONESIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. INDONESIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. INDONESIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. INDONESIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. JAPAN PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. JAPAN PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. JAPAN PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. JAPAN PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. MALAYSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. MALAYSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. MALAYSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. MALAYSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. PHILIPPINES PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. PHILIPPINES PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. PHILIPPINES PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. PHILIPPINES PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. SOUTH KOREA PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. SOUTH KOREA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. SOUTH KOREA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. SOUTH KOREA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. THAILAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. THAILAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. THAILAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. THAILAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. FRANCE PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. FRANCE PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. FRANCE PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. FRANCE PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. GERMANY PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. GERMANY PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. GERMANY PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. GERMANY PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. ITALY PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. ITALY PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. ITALY PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. ITALY PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. NETHERLANDS PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. NETHERLANDS PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. NETHERLANDS PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. NETHERLANDS PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 106. QATAR PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 107. QATAR PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 108. QATAR PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 109. QATAR PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 110. RUSSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 111. RUSSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 112. RUSSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 113. RUSSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 114. SAUDI ARABIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 115. SAUDI ARABIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 116. SAUDI ARABIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 117. SAUDI ARABIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 118. SOUTH AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 119. SOUTH AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 120. SOUTH AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 121. SOUTH AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 122. SPAIN PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 123. SPAIN PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 124. SPAIN PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 125. SPAIN PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 126. UNITED ARAB EMIRATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 127. UNITED ARAB EMIRATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 128. UNITED ARAB EMIRATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 129. UNITED ARAB EMIRATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 130. UNITED KINGDOM PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 131. UNITED KINGDOM PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 132. UNITED KINGDOM PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 133. UNITED KINGDOM PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 134. GLOBAL PNEUMOCOCCAL VACCINE MARKET: SCORES
TABLE 135. GLOBAL PNEUMOCOCCAL VACCINE MARKET: BUSINESS STRATEGY
TABLE 136. GLOBAL PNEUMOCOCCAL VACCINE MARKET: PRODUCT SATISFACTION
TABLE 137. GLOBAL PNEUMOCOCCAL VACCINE MARKET: RANKING
TABLE 138. GLOBAL PNEUMOCOCCAL VACCINE MARKET: MERGER & ACQUISITION
TABLE 139. GLOBAL PNEUMOCOCCAL VACCINE MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 140. GLOBAL PNEUMOCOCCAL VACCINE MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 141. GLOBAL PNEUMOCOCCAL VACCINE MARKET: INVESTMENT & FUNDING
TABLE 142. GLOBAL PNEUMOCOCCAL VACCINE MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 143. GLOBAL PNEUMOCOCCAL VACCINE MARKET: LICENSE & PRICING
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY POLYSACCHARIDE VACCINES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY BRONCHITIS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY MENINGITIS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY PNEUMONIA, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY SEPSIS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY PNEUMOVAX23, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY PREVNAR 13, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY SYNFLORIX, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY GOVERNMENT AUTHORITIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY NON-GOVERNMENTAL ORGANIZATIONS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. ARGENTINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. ARGENTINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. ARGENTINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. ARGENTINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. BRAZIL PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. BRAZIL PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. BRAZIL PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. BRAZIL PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. CANADA PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. CANADA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. CANADA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. CANADA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. MEXICO PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. MEXICO PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. MEXICO PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. MEXICO PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. UNITED STATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. UNITED STATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. UNITED STATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. UNITED STATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. AUSTRALIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. AUSTRALIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. AUSTRALIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. AUSTRALIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. CHINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. CHINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. CHINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. CHINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. INDIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. INDIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. INDIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. INDIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. INDONESIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. INDONESIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. INDONESIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. INDONESIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. JAPAN PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. JAPAN PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. JAPAN PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. JAPAN PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. MALAYSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. MALAYSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. MALAYSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. MALAYSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. PHILIPPINES PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. PHILIPPINES PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. PHILIPPINES PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. PHILIPPINES PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. SOUTH KOREA PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. SOUTH KOREA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. SOUTH KOREA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. SOUTH KOREA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. THAILAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. THAILAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. THAILAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. THAILAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. FRANCE PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. FRANCE PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. FRANCE PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. FRANCE PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. GERMANY PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. GERMANY PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. GERMANY PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. GERMANY PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. ITALY PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. ITALY PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. ITALY PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. ITALY PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. NETHERLANDS PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. NETHERLANDS PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. NETHERLANDS PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. NETHERLANDS PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 106. QATAR PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 107. QATAR PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 108. QATAR PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 109. QATAR PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 110. RUSSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 111. RUSSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 112. RUSSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 113. RUSSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 114. SAUDI ARABIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 115. SAUDI ARABIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 116. SAUDI ARABIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 117. SAUDI ARABIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 118. SOUTH AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 119. SOUTH AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 120. SOUTH AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 121. SOUTH AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 122. SPAIN PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 123. SPAIN PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 124. SPAIN PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 125. SPAIN PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 126. UNITED ARAB EMIRATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 127. UNITED ARAB EMIRATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 128. UNITED ARAB EMIRATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 129. UNITED ARAB EMIRATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 130. UNITED KINGDOM PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 131. UNITED KINGDOM PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 132. UNITED KINGDOM PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 133. UNITED KINGDOM PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 134. GLOBAL PNEUMOCOCCAL VACCINE MARKET: SCORES
TABLE 135. GLOBAL PNEUMOCOCCAL VACCINE MARKET: BUSINESS STRATEGY
TABLE 136. GLOBAL PNEUMOCOCCAL VACCINE MARKET: PRODUCT SATISFACTION
TABLE 137. GLOBAL PNEUMOCOCCAL VACCINE MARKET: RANKING
TABLE 138. GLOBAL PNEUMOCOCCAL VACCINE MARKET: MERGER & ACQUISITION
TABLE 139. GLOBAL PNEUMOCOCCAL VACCINE MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 140. GLOBAL PNEUMOCOCCAL VACCINE MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 141. GLOBAL PNEUMOCOCCAL VACCINE MARKET: INVESTMENT & FUNDING
TABLE 142. GLOBAL PNEUMOCOCCAL VACCINE MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 143. GLOBAL PNEUMOCOCCAL VACCINE MARKET: LICENSE & PRICING
LIST OF FIGURES
FIGURE 1. GLOBAL PNEUMOCOCCAL VACCINE MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL PNEUMOCOCCAL VACCINE MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2020 (USD MILLION)
FIGURE 5. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2020 (USD MILLION)
FIGURE 6. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2020 (USD MILLION)
FIGURE 7. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2020 (USD MILLION)
FIGURE 8. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 9. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 10. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 11. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 12. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 13. GLOBAL PNEUMOCOCCAL VACCINE MARKET: MARKET DYNAMICS
FIGURE 14. GLOBAL PNEUMOCOCCAL VACCINE MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 15. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2020 VS 2025 (%)
FIGURE 16. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2025
FIGURE 18. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINES, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2020 VS 2025 (%)
FIGURE 21. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2020 VS 2025 (USD MILLION)
FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2025
FIGURE 23. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY BRONCHITIS, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY MENINGITIS, 2020 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY PNEUMONIA, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY SEPSIS, 2020 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2020 VS 2025 (%)
FIGURE 28. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2020 VS 2025 (USD MILLION)
FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2025
FIGURE 30. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY PNEUMOVAX23, 2020 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY PREVNAR 13, 2020 VS 2025 (USD MILLION)
FIGURE 32. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY SYNFLORIX, 2020 VS 2025 (USD MILLION)
FIGURE 33. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2020 VS 2025 (%)
FIGURE 34. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2020 VS 2025 (USD MILLION)
FIGURE 35. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2025
FIGURE 36. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY GOVERNMENT AUTHORITIES, 2020 VS 2025 (USD MILLION)
FIGURE 37. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY NON-GOVERNMENTAL ORGANIZATIONS, 2020 VS 2025 (USD MILLION)
FIGURE 38. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 39. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 40. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 41. ARGENTINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 42. BRAZIL PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. CANADA PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. MEXICO PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. UNITED STATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 47. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 48. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 49. AUSTRALIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. CHINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. INDIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. INDONESIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. JAPAN PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. MALAYSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 55. PHILIPPINES PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. SOUTH KOREA PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. THAILAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 59. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 60. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 61. FRANCE PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 62. GERMANY PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 63. ITALY PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. NETHERLANDS PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 65. QATAR PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 66. RUSSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 67. SAUDI ARABIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 68. SOUTH AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 69. SPAIN PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 70. UNITED ARAB EMIRATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 71. UNITED KINGDOM PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 72. GLOBAL PNEUMOCOCCAL VACCINE MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 73. GLOBAL PNEUMOCOCCAL VACCINE MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 74. GLOBAL PNEUMOCOCCAL VACCINE MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 75. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL PNEUMOCOCCAL VACCINE MARKET, BY TYPE
FIGURE 1. GLOBAL PNEUMOCOCCAL VACCINE MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL PNEUMOCOCCAL VACCINE MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2020 (USD MILLION)
FIGURE 5. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2020 (USD MILLION)
FIGURE 6. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2020 (USD MILLION)
FIGURE 7. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2020 (USD MILLION)
FIGURE 8. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 9. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 10. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 11. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 12. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 13. GLOBAL PNEUMOCOCCAL VACCINE MARKET: MARKET DYNAMICS
FIGURE 14. GLOBAL PNEUMOCOCCAL VACCINE MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 15. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2020 VS 2025 (%)
FIGURE 16. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2025
FIGURE 18. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINES, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2020 VS 2025 (%)
FIGURE 21. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2020 VS 2025 (USD MILLION)
FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2025
FIGURE 23. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY BRONCHITIS, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY MENINGITIS, 2020 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY PNEUMONIA, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY SEPSIS, 2020 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2020 VS 2025 (%)
FIGURE 28. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2020 VS 2025 (USD MILLION)
FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2025
FIGURE 30. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY PNEUMOVAX23, 2020 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY PREVNAR 13, 2020 VS 2025 (USD MILLION)
FIGURE 32. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY SYNFLORIX, 2020 VS 2025 (USD MILLION)
FIGURE 33. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2020 VS 2025 (%)
FIGURE 34. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2020 VS 2025 (USD MILLION)
FIGURE 35. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2025
FIGURE 36. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY GOVERNMENT AUTHORITIES, 2020 VS 2025 (USD MILLION)
FIGURE 37. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY NON-GOVERNMENTAL ORGANIZATIONS, 2020 VS 2025 (USD MILLION)
FIGURE 38. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 39. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 40. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 41. ARGENTINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 42. BRAZIL PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. CANADA PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. MEXICO PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. UNITED STATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 47. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 48. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 49. AUSTRALIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. CHINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. INDIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. INDONESIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. JAPAN PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. MALAYSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 55. PHILIPPINES PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. SOUTH KOREA PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. THAILAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 59. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 60. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 61. FRANCE PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 62. GERMANY PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 63. ITALY PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. NETHERLANDS PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 65. QATAR PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 66. RUSSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 67. SAUDI ARABIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 68. SOUTH AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 69. SPAIN PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 70. UNITED ARAB EMIRATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 71. UNITED KINGDOM PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 72. GLOBAL PNEUMOCOCCAL VACCINE MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 73. GLOBAL PNEUMOCOCCAL VACCINE MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 74. GLOBAL PNEUMOCOCCAL VACCINE MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 75. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL PNEUMOCOCCAL VACCINE MARKET, BY TYPE
